ReviewTherapeutics and clinical risk management2021
Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis.
Review in Therapeutics and clinical risk management, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07349901 (Predicting Hospital Readmission for Surgical Patients Using Deep Learning Models With Smart Watch and Smart Ring Sensors Data), which is not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Predicting Hospital Readmission for Surgical Patients Using Deep Learning Models With Smart Watch and Smart Ring Sensors Data
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Comparative Effectiveness of Non-Pharmacological Interventions for Reducing Heart Failure-Related Unplanned Readmissions: A Systematic Review and Network Meta-Analysis.Journal of clinical medicine · 2026Review
- Operationalizing a Decision-Making for Adverse Event Reporting Toolkit (DART) for Aging and Serious Illness Research.Journal of the American Geriatrics Society · 2026Article
- Spatial distribution of electromyographic activity in the vastus lateralis muscle during different contraction tasks in patients with heart failure.Heart and vessels · 2026Article
- Discharge neutrophily-to-lymphocyte ratio and its trajectory as predictors of 30-day outcomes in acute heart failure.ESC heart failure · 2026Article
- Impact of ethnicity on long-term mortality following hospitalization for acute decompensated heart failure: a retrospective cohort study.BMC cardiovascular disorders · 2026Article
- In-hospital inflammatory-nutritional-renal trajectory phenotypes and 90-day readmission or mortality in patients with acute decompensated heart failure: a retrospective cohort study.Frontiers in cardiovascular medicine · 2026Article
- Predicting 30-Days Hospital Readmission for Patients with Heart Failure Using Electronic Health Record Embeddings: Comparative Evaluation.JMIR medical informatics · 2025Article
- Lifetime Healthcare and Long-Term Care Costs of Heart Failure: Estimates Using Administrative Data from Hospitalized Patients in the Netherlands.PharmacoEconomics · 2025Article
- The Role of Mechanical Economy and Efficiency as Key Drivers of Cardiac Rehabilitation Exercise Performance Improvement in a Patient With Heart Failure and an Implanted CRT-D: A Case Report and Literature Review.Clinical case reports · 2025Article
- Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure.ESC heart failure · 2025Article
- Multidisciplinary initiative to reduce 30-day readmissions in heart failure: a quality improvement perspective.BMJ open quality · 2025Article
- External Exposome Factors and Adverse Heart Failure Outcomes in the OneFlorida+ Network: Retrospective Cohort Study.JMIR formative research · 2025Article
- Prescription of guideline-directed medical therapy in heart failure: impact on mortality and readmission.ESC heart failure · 2025Article
- Predicting death or readmission following heart failure hospitalisation: the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry.Open heart · 2025Article
- Neighborhood Deprivation and Racial Disparities in Heart Failure Outcomes: A Counterfactual Approach.JACC. Advances · 2025Article
- Time to Readmission and Its Prognostic Factors among Hospitalised Heart Failure Patients.The Malaysian journal of medical sciences : MJMS · 2025Article
- Positive Psychology Insights on the Effects of Spirituality on Shared Decision-Making in Patients with Chronic Heart Failure: The Chain-Mediated Effects of Benefit-Finding and Decision Self-Efficacy.Healthcare (Basel, Switzerland) · 2025Article
- Sex-specific association of comorbid heart failure on mortality after Alzheimer's disease diagnosis in older adults aged 75 years and above: A health insurance claims data analysis in Japan.Journal of Alzheimer's disease : JAD · 2025Article
- Exploring Mortality and Prognostic Factors of Heart Failure with In-Hospital and Emergency Patients by Electronic Medical Records: A Machine Learning Approach.Risk management and healthcare policy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF).
settingA systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. The random-effects model was utilized to evaluate the pooled results.
participantsA total of 27 studies with 515,238 participants were finally meta-analysed. The HF patients had an average age of 76.3 years, with 51% of the sample being male, in the pooled analysis. PRIMARY AND SECONDARY OUTCOME MEASURES: The outcome measures were 30-day and 1-year readmission rates, mortality, and risk factors for readmission and mortality.
resultsThe effect sizes for readmission and mortality were estimated as the mean and 95% confidence interval (CI). The estimated 30-day and 1-year all-cause readmission rates were 0.19 (95% CI 0.14-0.23) and 0.53 (95% CI 0.46-0.59), respectively, while the all-cause mortality rates were 0.14 (95% CI 0.10-0.18) and 0.29 (95% CI 0.25-0.33), respectively. Comorbidities were highly prevalent in individuals with HF.
conclusionHeart failure hospitalization is followed by high readmission and mortality rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.